Showing results (521-530 of 728) with videos related to

Sort By:
Pageof 73
Biorxiv : the Preprint Server for Biology|June 25, 2024
IsoBayes: a Bayesian approach for single-isoform proteomics inferenceJordy Bollon, Michael R Shortreed, Ben T Jordan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2023
Parthenolide As a Therapeutic for Disseminated Canine NeoplasmsLisa J Schlein, Samuel A Brill, Rachel V Brady, et al.
Neurology|September 20, 2023
The Brain Health Imperative in the 21st Century-A Call to Action: The AAN Brain Health Platform and Position StatementNatalia S Rost, Joel Salinas, Justin T Jordan, et al.
Experimental Hematology|May 29, 2019
CD123 CAR T cells for the treatment of myelodysplastic syndromeBrett M Stevens, Wei Zhang, Daniel A Pollyea, et al.
American Journal of Medical Genetics. Part A|June 9, 2022
Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosisVanessa L Merker, Bronwyn Slobogean, Justin T Jordan, et al.
The Journal of Clinical Psychiatry|September 6, 2024
Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine for Major Depressive Disorder: Findings From Placebo-Controlled TrialsJoshua T Jordan, Li Shen, Nicholas J Cooper, et al.
Nature Communications|July 4, 2018
Photo-tautomerization of acetaldehyde as a photochemical source of formic acid in the troposphereMiranda F Shaw, Bálint Sztáray, Lisa K Whalley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2024
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug ResistanceLorraine N Davis, Zachary J Walker, Lauren T Reiman, et al.
The Oncologist|April 10, 2020
The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of ToxicitiesLaura J Klesse, Justin T Jordan, Heather B Radtke, et al.
European Journal of Medicinal Chemistry|July 6, 2021
Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD)Narsimha R Penthala, Meenakshisundaram Balasubramaniam, Soma Shekar Dachavaram, et al.
Pageof 73